May 4, 2020
Arcturus Therapeutics, Catalent to make COVID-19 vaccine
Arcturus Therapeutics and Catalent have entered a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to protect against the SARS-CoV-2 coronavirus.